...
首页> 外文期刊>Epilepsia Open >Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice
【24h】

Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice

机译:拉考酰胺联合治疗期间药物负荷的变化:德国和奥地利临床实践中的一项非干预性观察性研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction Effects of antiepileptic drug (AED) load changes in patients with focal seizures have not been well evaluated. Methods SP1065 (NCT01673282) was a noninterventional, prospective, observational study conducted in a clinical practice setting. Patients (aged ≥18?years) with focal seizures were enrolled within 7?days of being prescribed adjunctive lacosamide. Observation period was ~6?months. Drug load was assessed using percentage change in ratio of actual prescribed dose and World Health Organization defined daily dose (DDD) for concomitant AEDs and all AEDs (including lacosamide). Subgroups were defined for patients with at least one concomitant sodium channel–blocking AED (SCB [+]) and those without (SCB [?]). Results A total of 311 patients were assessed for safety, 302 for measurement of drug load, and 240 for effectiveness. Ratio of AED dose to DDD decreased for concomitant AEDs (?9.6%) and increased for all AEDs (including lacosamide; 15.5%). Median reduction in focal seizure frequency per 28?days was 100% (range: ?100, 2275.8). 70.4% and 61.7% of patients had a ≥50% or ≥75% reduction in seizure frequency, respectively; 50.8% became seizure‐free. In the SCB (+) subgroup (n?=?149), ratio of AED dose to DDD decreased for concomitant AEDs (?15.0%) and increased for all AEDs (10.7%). In the SCB (?) subgroup (n?=?153), ratio of AED dose to DDD decreased for concomitant AEDs (?4.4%) and increased for all AEDs (20.2%). Fifty‐seven patients (18.3%) reported ADRs, most commonly dose 400?mg/d (7.1%). Seventeen patients (5.5%) had ADRs leading to discontinuation. Significance Addition of lacosamide resulted in reduction of concomitant AED drug load regardless of whether concomitant AEDs were SCB (+) or SCB (?). These results indicate that addition of lacosamide in patients with focal seizures could allow clinicians to withdraw or reduce the dose of less well‐tolerated or less effective AEDs.
机译:简介抗癫痫药(AED)负荷变化对局灶性癫痫患者的影响尚未得到很好的评估。方法SP1065(NCT01673282)是一项在临床实践中进行的非干预性前瞻性观察性研究。患有局灶性癫痫发作的患者(≥18岁)在开具辅助性拉可酰胺治疗后7天之内入组。观察期为〜6个月。使用实际处方剂量与世界卫生组织定义的并发AED和所有AED(包括拉考酰胺)的每日剂量(DDD)的百分比变化来评估药物负荷。亚组的定义是至少有一种同时发生钠通道阻滞的AED(SCB [+])和没有(SCB [?])的患者。结果总共对311例患者进行了安全性评估,对302例进行了药物负荷评估,对240例进行了有效性评估。伴随的AED的AED剂量与DDD的比率降低了(?9.6%),而所有AED的AED剂量对DDD的比率都增加了(包括拉考酰胺; 15.5%)。每28天的局灶性发作频率中位数降低为100%(范围:?100,2275.8)。分别有70.4%和61.7%的患者癫痫发作频率降低了50%或75%以上; 50.8%无癫痫发作。在SCB(+)亚组(n?=?149)中,伴随AED的AED剂量与DDD的比率降低(?15.0%),而所有AED的AED剂量与DDD的比率增加(10.7%)。在SCB(?)子组(n?=?153)中,伴随AED的AED剂量与DDD的比率降低(?4.4%),而所有AED的AED剂量与DDD的比率增加(20.2%)。五十七例患者(18.3%)报告了ADR,最常见的剂量是> 400?mg / d(7.1%)。十七名患者(5.5%)患有ADRs导致停用。重要性无论是否伴有AED为SCB(+)或SCB(?),加入Lacosamide都会降低伴有AED的药物负荷。这些结果表明,在局灶性癫痫发作患者中加入拉考酰胺可以使临床医生撤回或减少耐受性较差或疗效较差的AED的剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号